Price T Rowe Associates Inc Bio Techne Corp Transaction History

Price T Rowe Associates Inc

  • $883 Billion
  • Q2 2025

A detailed history of Price T Rowe Associates Inc transactions in Bio Techne Corp stock. As of the latest transaction made, Price T Rowe Associates Inc holds 8,847,931 shares of TECH stock, worth $467 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
8,847,931
Previous 11,375,279 22.22%
Holding current value
$467 Million
Previous $667 Million 31.74%
% of portfolio
0.05%
Previous 0.08%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$46.66 - $58.38 $118 Million - $148 Million
-2,527,348 Reduced 22.22%
8,847,931 $455 Million
Q1 2025

May 14, 2025
BUY
$58.47 - $78.75 $42.2 Million - $56.8 Million
721,012 Added 6.77%
11,375,279 $667 Million
Q4 2024

Feb 14, 2025
BUY
$66.37 - $78.17 $81.6 Million - $96.1 Million
1,229,954 Added 13.05%
10,654,267 $767 Million
Q3 2024

Nov 14, 2024
BUY
$70.96 - $82.35 $63.8 Million - $74 Million
898,541 Added 10.54%
9,424,313 $753 Million
Q2 2024

Aug 14, 2024
BUY
$62.12 - $84.15 $173 Million - $234 Million
2,779,653 Added 48.37%
8,525,772 $611 Million
Q1 2024

May 15, 2024
BUY
$65.98 - $77.09 $182 Million - $212 Million
2,755,065 Added 92.11%
5,746,119 $404 Million
Q4 2023

Feb 14, 2024
SELL
$52.83 - $78.22 $45.8 Million - $67.8 Million
-866,612 Reduced 22.46%
2,991,054 $231 Million
Q3 2023

Nov 14, 2023
SELL
$67.52 - $89.42 $14.2 Million - $18.8 Million
-209,763 Reduced 5.16%
3,857,666 $263 Million
Q2 2023

Aug 14, 2023
BUY
$73.76 - $85.98 $263 Million - $306 Million
3,559,781 Added 701.23%
4,067,429 $332 Million
Q1 2023

May 15, 2023
SELL
$71.62 - $86.62 $40.2 Million - $48.7 Million
-561,663 Reduced 52.53%
507,648 $37.7 Million
Q4 2022

Feb 14, 2023
BUY
$80.67 - $352.29 $62.9 Million - $275 Million
779,246 Added 268.65%
1,069,311 $88.6 Million
Q3 2022

Nov 14, 2022
BUY
$282.54 - $391.85 $10.9 Million - $15.1 Million
38,563 Added 15.33%
290,065 $82.4 Million
Q2 2022

Aug 15, 2022
SELL
$322.67 - $449.65 $2.5 Million - $3.48 Million
-7,744 Reduced 2.99%
251,502 $87.2 Million
Q1 2022

May 16, 2022
SELL
$353.85 - $487.79 $3.75 Million - $5.16 Million
-10,586 Reduced 3.92%
259,246 $112 Million
Q4 2021

Feb 14, 2022
BUY
$456.15 - $525.06 $14.3 Million - $16.5 Million
31,364 Added 13.15%
269,832 $140 Million
Q3 2021

Nov 15, 2021
BUY
$444.87 - $538.88 $36.1 Million - $43.7 Million
81,156 Added 51.59%
238,468 $116 Million
Q2 2021

Aug 16, 2021
SELL
$387.35 - $450.26 $4.99 Million - $5.81 Million
-12,895 Reduced 7.58%
157,312 $70.8 Million
Q1 2021

May 17, 2021
SELL
$314.62 - $411.0 $2.7 Million - $3.52 Million
-8,570 Reduced 4.79%
170,207 $65 Million
Q4 2020

Feb 16, 2021
BUY
$246.9 - $321.87 $44.1 Million - $57.5 Million
178,777 New
178,777 $56.8 Million

Others Institutions Holding TECH

# of Institutions
612
Shares Held
161M
Call Options Held
229K
Put Options Held
70.3K
View Full List

About BIO-TECHNE Corp

TECH Quotes by TradingView
  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.07B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email